Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 1
2015 1
2018 1
2019 1
2021 2
2022 1
2023 3
2024 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Dysautonomia: a common comorbidity of systemic disease.
Blitshteyn S. Blitshteyn S. Immunol Res. 2025 Jul 8;73(1):105. doi: 10.1007/s12026-025-09661-2. Immunol Res. 2025. PMID: 40624434 Free PMC article. Review.
The most common autonomic disorders encountered in clinical practice are postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope (NCS), and orthostatic hypotension (OH), which may be undiagnosed or often mislabeled with psychiatric disorders. ...Treatmen …
The most common autonomic disorders encountered in clinical practice are postural orthostatic tachycardia syndrome (POTS), neurocardi …
Dysautonomia: A Forgotten Condition - Part 1.
Rocha EA, Mehta N, Távora-Mehta MZP, Roncari CF, Cidrão AAL, Elias Neto J. Rocha EA, et al. Arq Bras Cardiol. 2021 Apr;116(4):814-835. doi: 10.36660/abc.20200420. Arq Bras Cardiol. 2021. PMID: 33886735 Free PMC article. English, Portuguese.
Various drugs can be used for symptomatic nOH, especially fludrocortisone, midodrine and droxidopa, the latter not available in Brazil. The risk of exacerbation or triggering supine hypertension should be considered. ...Various drugs can be used for symptomatic nOH, …
Various drugs can be used for symptomatic nOH, especially fludrocortisone, midodrine and droxidopa, the latter not available i …
Clinical neurophysiology of postural tachycardia syndrome.
Cutsforth-Gregory JK, Sandroni P. Cutsforth-Gregory JK, et al. Handb Clin Neurol. 2019;161:429-445. doi: 10.1016/B978-0-444-64142-7.00066-7. Handb Clin Neurol. 2019. PMID: 31307619 Review.
The objectives of POTS management are to (1) increase the time that patients can stand, perform daily activities, and exercise and (2) avoid syncope. Management involves nonpharmacologic (fluid and salt loading, physical countermaneuvers, compression garments, exercise tra …
The objectives of POTS management are to (1) increase the time that patients can stand, perform daily activities, and exercise and (2 …
[Postural tachycardia syndrome (PoTS): An up-to-date].
Astudillo L, Laure A, Fabry V, Pugnet G, Maury P, Labrunée M, Sailler L, Pavy-Le Traon A. Astudillo L, et al. Rev Med Interne. 2018 Aug;39(8):627-634. doi: 10.1016/j.revmed.2018.04.017. Epub 2018 Jun 13. Rev Med Interne. 2018. PMID: 29909001 Review. French.
Postural tachycardia syndrome (PoTS) is a multifactorial syndrome defined by an increase in heart rate 30bpm, within 10minutes of standing (or during a head up tilt test to at least 60 ), in absence of orthostatic hypotension. ...The treatment is based on nonpharmacologic …
Postural tachycardia syndrome (PoTS) is a multifactorial syndrome defined by an increase in heart rate 30bpm, within 10minutes of st …
Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies.
Narasimhan B, Aggarwal D, Satish P, Kantharia B, Aronow WS. Narasimhan B, et al. Expert Opin Investig Drugs. 2022 Oct;31(10):1017-1025. doi: 10.1080/13543784.2022.2121697. Epub 2022 Sep 11. Expert Opin Investig Drugs. 2022. PMID: 36094001 Review.
INTRODUCTION: Postural orthostatic tachycardia syndrome (POTS) is an increasingly well-recognized condition encountered in clinical practice. Diagnosis and treatment remain extremely challenging. ...Lifestyle measures form the first line of therapy, followed by beta-blocke …
INTRODUCTION: Postural orthostatic tachycardia syndrome (POTS) is an increasingly well-recognized condition encountered in clinical p …
Postural Orthostatic Tachycardia Syndrome After COVID-19: A Systematic Review of Therapeutic Interventions.
Abbate G, De Iulio B, Thomas G, Priday A, Biondi-Zoccai G, Markley R, Abbate A. Abbate G, et al. J Cardiovasc Pharmacol. 2023 Jul 1;82(1):23-31. doi: 10.1097/FJC.0000000000001432. J Cardiovasc Pharmacol. 2023. PMID: 37094584
Most cases had mild COVID-19 symptoms. The most common POTS symptoms were palpitations, chest pain, lightheadedness, and debilitating fatigue. ...Subjects received different treatments, the most common being beta-adrenergic blockers (ie, propranolol), mineral corticosteroi …
Most cases had mild COVID-19 symptoms. The most common POTS symptoms were palpitations, chest pain, lightheadedness, and debilitating …
Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review.
Vasavada AM, Verma D, Sheggari V, Ghetiya S, Chirumamilla PC, Kotak RA, Mahapatra SS, Patel T, Jain M. Vasavada AM, et al. Cureus. 2023 May 11;15(5):e38887. doi: 10.7759/cureus.38887. eCollection 2023 May. Cureus. 2023. PMID: 37313107 Free PMC article. Review.
Results demonstrated that pharmacologic treatment options for POTS were effective in reducing symptoms of POTS, but most of the studies were underpowered. Several were terminated due to various reasons. Midodrine ivabradine, bisoprolol, fludrocortisone …
Results demonstrated that pharmacologic treatment options for POTS were effective in reducing symptoms of POTS, but most of th …
Postural tachycardia syndrome: a heterogeneous and multifactorial disorder.
Benarroch EE. Benarroch EE. Mayo Clin Proc. 2012 Dec;87(12):1214-25. doi: 10.1016/j.mayocp.2012.08.013. Epub 2012 Nov 1. Mayo Clin Proc. 2012. PMID: 23122672 Free PMC article. Review.
POTS manifests with symptoms of cerebral hypoperfusion and excessive sympathoexcitation. ...Management of POTS includes avoidance of precipitating factors, volume expansion, physical countermaneuvers, exercise training, pharmacotherapy (fludrocortisone, mi …
POTS manifests with symptoms of cerebral hypoperfusion and excessive sympathoexcitation. ...Management of POTS includes avoida …
Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination.
Gómez-Moyano E, Rodríguez-Capitán J, Gaitán Román D, Reyes Bueno JA, Villalobos Sánchez A, Espíldora Hernández F, González Angulo GE, Molina Mora MJ, Thurnhofer-Hemsi K, Molina-Ramos AI, Romero-Cuevas M, Jiménez-Navarro M, Pavón-Morón FJ. Gómez-Moyano E, et al. Front Neurol. 2023 Aug 16;14:1221518. doi: 10.3389/fneur.2023.1221518. eCollection 2023. Front Neurol. 2023. PMID: 37654428 Free PMC article. Review.
POTS can lead to debilitating symptoms, significant disability, and impaired quality of life. ...Pharmacotherapy, such as beta-blockers, fludrocortisone, midodrine, and ivabradine, may also be used in selected cases. Further research is needed to understand t …
POTS can lead to debilitating symptoms, significant disability, and impaired quality of life. ...Pharmacotherapy, such as beta-blocke …
Management of Postural Orthostatic Tachycardia Syndrome in Pediatric Patients: A Clinical Review.
Huynh P, Brown A, Campisi L, Mruk A, Nguyen T, Raschka M, Afolabi T. Huynh P, et al. J Pediatr Pharmacol Ther. 2024 Oct;29(5):456-467. doi: 10.5863/1551-6776-29.5.456. Epub 2024 Oct 14. J Pediatr Pharmacol Ther. 2024. PMID: 39411411 Free PMC article.
Published literature regarding POTS primarily focuses on the adult population, and guidance on treatment in pediatrics is sparse. ...Although the body of evidence for the management of POTS is expanding, additional research is needed to determine safe and efficaciou …
Published literature regarding POTS primarily focuses on the adult population, and guidance on treatment in pediatrics is sparse. ... …
15 results